THE EFFECT OF LYMPHOCYTE SUBSETS IN ALLOGENEIC BONE MARROW TRANSPLANTATION ON RELAPSE, GRAFT VERSUS HOST DISEASE AND SURVIVAL: A SINGLE-CENTER EXPERIENCE

EHA Library, Pelin Ozturk, 419447

IMPACT OF BASELINE RENAL FUNCTION ON HAPLOIDENTICAL STEM CELL TRANSPLANTATION OUTCOMES

EHA Library, Samer Srour, 419448

OPTIMIZATION OF LOW-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Mohammad Tarek, 419449

CYTOMEGALOVIRUS (CMV) REACTIVATION POST ALLOGENEIC STEM CELL TRANSPLANT (ALLO-SCT) IN THE LETERMOVIR ERA- THE GREEK TRANSPLANT EXPERIENCE: IS IT ADEQUATE AND UNTIL WHEN?

EHA Library, Evridiki Theodorou, 419450

MAINTENANCE THERAPY WITH ORAL DECITABINE PLUS CEDAZURIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

EHA Library, Portia Smallbone, 419451

ACUTE LYMPHOBLASTIC LEUKEMIA AND ALLOGENIC STEM CELL TRANSPLANT: QUANTITATIVE SYNTHESIS REPORT

EHA Library, Lacey Williams, 419452

PROSPECTIVE ANALYSIS OF URINARY EXCRETION OF BK AND JC VIRUSES IN ALLO-TPH RECEPTORS TO PREVENT THE DEVELOPMENT OF HEMORRHAGIC CYSTITIS

EHA Library, Carmen Loredo Alvarez, 419453

BETTER PRE-TRANSPLANT TREATMENT OPTIONS FOR TP53-MUTATED MDS: CYTOREDUCTIVE OR NON-CYTOREDUCTIVE THERAPY?

EHA Library, Bingqian Jiang, 419454

EXPLORING THE PSYCHOLOGICAL EXPERIENCES AND NEEDS OF HAPLOIDENTICAL STEM CELL DONORS DONATING TO A PARENT OR AN ADULT CHILD: RESULTS OF A UK, MULTICENTER, QUALITATIVE STUDY

EHA Library, Rosalina Naidoo, 419455

ADMINISTRATION OF MELFALAN IN TWO DAYS (VS. ONE) ALONG WITH THE USE OF PROPHYLACTIC G-CSF AND ANTIBIOTICS IS ASOCIATED WITH A REDUCED RISK OF MUCOSITIS IN PATIENTS UNDERGOING ASCT FOR MULTIPLE MYELOMA

EHA Library, Irene Francés Alexandre, 419456

A PROSPECTIVE STUDY OF PTCY AS GVHD PROPHYLAXIS AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION USING LIPOSOME MITOXANTRONE IN COMBINATION WITH BUSULFAN AND FLUDARABINE CONDITIONING

EHA Library, Ruju Wang, 419457

PREDICTORS OF SURVIVAL AND SUCCESSFUL RESPONSE TO UPFRONT UC-MSC TREATMENT IN ACUTE GVHD PATIENTS: FINDINGS FROM A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED MULTICENTRE CLINICAL TRIAL

EHA Library, Sen Mui Tan, 419458

EXPLORING THE PROGNOSTIC VALUE OF PROGNOSTIC NUTRITIONAL INDEX AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, XiaoLi Chen, 419459

OLUTASIDENIB AS BRIDGE-TO-TRANSPLANT TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MIDH1 ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Stéphane De Botton, 419460

PERIPHERAL BLOOD STEM CELL COLLECTION IN ALLOGENEIC DONORS: HOW TO PREDICT CD34+ COUNT IN PRODUCT.

EHA Library, Tigran Torosian, 419461

A SINGLE CENTER EXPERIENCE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN AGED POPULATION.

EHA Library, Didier Blaise, 419462

CLINICAL MANIFESTATIONS, RISK FACTORS, CLINICAL OUTCOMES OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AFTER EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.

EHA Library, Dan Liu, 419463

LONG TERM EFFICACY RESULTS OF THE SIERRA TRIAL: A PHASE 3 STUDY OF 131I-APAMISTAMAB-LED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION VERSUS CONVENTIONAL CARE IN OLDER PATIENTS WITH ACTIVE, R/R AML

EHA Library, James M Foran, 419464

CARDIAC TOXICITY AFTER ALLO-HCT IN PATIENTS WITH AML TREATED WITH PTCY-BASED PROPHYLAXIS. STUDY CONDUCTED ON BEHALF OF THE GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO Y TERAPIA CELULAR (GETH-TC)

EHA Library, Maria Queralt Salas, 419465

ANALYSIS OF CAR-T CELL CHIMERISM AFTER CD7 CAR-T CELL BRIDGING MYELOABLATIVE CONDITIONING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Sihan Lai, 419466

DIFFERENTIATING ERYTHROBLASTS ADAPT TO TURBULENT FLOW BY ACCELERATING MATURATION AND ACTIVATING CHOLESTEROL BIOSYNTHESIS

EHA Library, Giulia Iacono, 419467

LOSS OF SFRP1 IN NICHE CELLS AND ITS IMPACT ON THE HEMATOPOIESIS

EHA Library, Emely Schönhals, 419468

IDENTIFICATION AND CHARACTERIZATION OF NOVEL SITES OF EXTRAMEDULLARY HEMATOPOIESIS UNDER CHRONIC INFLAMMATORY CONDITIONS

EHA Library, Maria Kuzmina, 419469

THE SELECTIVE ADVANTAGE OF TET2-/- HSC IS ASSOCIATED WITH AN EPIGENETIC SWITCH AT TRANSPOSABLE ELEMENTS THAT PROTECTS THEM FROM CHRONIC INFLAMMATION.

EHA Library, Anne STOLZ, 419470

ELTD1 NEGATIVELY REGULATES DIFFERENTIATION OF HEMOGENIC ENDOTHELIAL CELLS FROM HUMAN EMBRYONIC STEM CELLS THROUGH WNT/HPIP PATHWAY

EHA Library, Qian Luo, 419472

INFLAMMATION REMODELS THE BONE MARROW NICHE AND T-CELL LANDSCAPE IN HUMAN CLONAL HAEMATOPOIESIS AND ASSOCIATED MYELODYSPLASIA

EHA Library, Borhane Guezguez, 419473

DNA METHYLATION JOINTLY ENCODES CLONAL IDENTITY AND CELL STATE IN SINGLE HEMATOPOIETIC CELLS

EHA Library, Martina Braun, 419474

HETEROGENEOUS STROMAL POPULATIONS CHARACTERIZE THE BONE MARROW MICROENVIRONMENT IN B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Mauricio Ferrao Blanco, 419475

UNRAVELING THE IMPACT OF STAG2 MUTATIONS IN MDS AND AML.

EHA Library, Eve Dias, 419476

COMPREHENSIVE IDENTIFICATION OF PLEIOTROPIC ASSOCIATIONS FOR CLONAL HAEMATOPOIESIS OF INDETERMINATE POTENTIAL.

EHA Library, Esther Hazane Leroyer, 419477

BRIQUILIMAB POTENTLY INHIBITS SCF/C-KIT SIGNALING, WHICH DOES NOT INDUCE HEALTHY HUMAN HEMATOPOIETIC STEM CELL (HSC) APOPTOSIS, BUT SKEWS HSC DIFFERENTIATION POTENTIAL.

EHA Library, Hye-Sook Kwon, 419478

THE ROLE OF STATHMIN-1 IN MITOCHONDRIAL AND CELLULAR FUNCTION IN HEMATOPOIETIC STEM CELLS

EHA Library, Luana Chiquetto, 419479

CRACKING THE BIOELECTRICAL CODE OF LEUKEMIC MSCS TO REROUTE BONE MARROW MICROENVIRONMENT

EHA Library, Ambra Da Ros, 419480

ACTIVATION OF PPARΔ IN BONE MARROW ENDOTHELIAL PROGENITOR CELLS REPAIRS THEIR HEMATOPOIESIS-SUPPORTING ABILITY AFTER MYELOSUPPRESSIVE INJURY

EHA Library, Mi Liang, 419481

BEMCENTINIB, AN AXL INHIBITOR, OVERCOMES MICROENVIRONMENT-MEDIATED RESISTANCE TO THE ANTI-LEUKEMIC ACTIVITY OF PIOGLITAZONE.

EHA Library, Valerie BARDET, 419482

DEFICIENCY HIF-1Α EXPRESSION IN BONE MARROW ENDOTHELIAL PROGENITOR CELLS PROMOTES ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Wen-Kai Zhang, 419483

NOVEL 3D CULTURE MODELS FOR STUDYING MYELOID NEOPLASIA

EHA Library, Sigrid Uxa, 419484

OPTIMIZATION AND APPLICATION OF MULTI-PRIME EDITING IN THE THERAPEUTIC APPROACH FOR GATA2 DEFICIENCY

EHA Library, ZHICHAO QIU, 419486

TARGETING THE ZAKΑ/P38/NLRP1 AXIS AS A NOVEL THERAPEUTIC STRATEGY FOR HEMATOPOIETIC DISORDERS ASSOCIATED WITH CHRONIC INFLAMMATION AND CONGENITAL ANEMIAS

EHA Library, Juan M Lozano-Gil, 419487

DECIPHERING THE EMERGENCE OF ERYTHRO-MYELOID PROGENITORS IN THE MOUSE YOLK SAC

EHA Library, Michaela Šímová, 419488

EVALUATION OF RED BLOOD CELL DISTRIBUTION WIDTH (RDW) AND MEAN CORPUSCULAR VOLUME (MCV) IN A CASE-COHORT STUDY OF HEALTHY SUBJECTS IN RELATION TO CANCER DIAGNOSIS.

EHA Library, Carmen Tartari, 419490

MYELOID LINEAGE COMMITMENT INSTRUCTED BY LMO4-MEDIATED GATA FACTOR REDISTRIBUTION AT THE CHROMATIN

EHA Library, Alexandre Fagnan, 419491

MESENCHYMAL STROMAL CELLS FROM INDIVIDUALS WITH DNMT3AMUT CLONAL HEMATOPOIESIS ACTIVELY SIGNAL TOWARDS HEALTHY HEMATOPOIETIC STEM/PROGENITOR CELLS SUPPRESSING THEIR CYCLING CAPACITY

EHA Library, Anna Navarro Figueredo, 419492

IDENTIFICATION AND MAINTENANCE OF QUIESCENT HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS IN VITRO WITH FLT3-LIGAND

EHA Library, Margarita MacAldaz, 419493

CHANGES AND RECONSTITUTION OF MARROW-INFILTRATING T LYMPHOCYTE SUBSETS IN THE EARLY STAGE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jeong Suk Koh, 419494

SINGLE-CELL RESOLVED LONGITUDINAL CLONAL DYNAMICS IN HUMAN HEMATOPOIESIS AND REGENERATION

EHA Library, Lena Nitsch, 419495

INDUCIBLE CXCL12/CXCR4-DEPENDENT EXTRAMEDULLARY HEMATOPOIETIC NICHES IN THE ADRENAL GLAND

EHA Library, Alejandro Alonso Calleja, 419496

LONG-TERM EX VIVO HAEMATOPOIETIC STEM CELL (HSC) EXPANSION USING BONE-DERIVED REINVIGORATING MESENCHYMAL STEM CELLS (RMSCS).

EHA Library, Sonia Fernández Torices, 419497

CD21 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

EHA Library, Nicola Maciocia, 419498

THE CD19-CAR COSTIMULATORY DOMAINS DIFFERENTLY AFFECT RESISTANCE DEVELOPMENT IN B-ALL AND B-CELL LYMPHOMA.

EHA Library, Marta Krawczyk, 419499

PRE-CLINICAL DEVELOPMENT OF AZD5492, A CD8-GUIDED T CELL ENGAGER, FOR B-NON HODGKIN LYMPHOMA INDICATIONS

EHA Library, Corinne Cayatte, 419500

GENETIC POLYMORPHISMS AND CLINICAL PARAMETERS ASSOCIATED WITH METHOTREXATE TOXICITY IN THAI ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCY RECEIVING HIGH-DOSE METHOTREXATE-CONTAINING REGIMENS

EHA Library, Palada Pitakkitnukun, 419501

DRESSING UP T CELLS WITH A PECULIAR TCR TARGETING CATHEPSIN G PEPTIDES ON TWO DIFFERENT HLA MOLECULES LEADS TO THE COMPLETE ERADICATION OF ACUTE MYELOID LEUKEMIA BLASTS IN VIVO

EHA Library, Francesca Marzuttini, 419502

PRECLINICAL DEVELOPMENT OF A CARLY3, A NEW CAR-T TREATMENT BASED ON CD79B FOR PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Beatriz Martín-Antonio, 419503

AN ALLOGENIC, NON-VIRAL, DOUBLE SITE KNOCK-IN CAR-T TARGETING CD19 AND BCMA

EHA Library, Lianjun Shen, 419504

DEVELOPMENT OF ANTI-CD21 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR T CELL ACUTE LYMPHOBLASTIC LEUKEMIA – CAR ENGINEERING FOR TARGETING A COMPLEX ANTIGEN.

EHA Library, Nicola Maciocia, 419505

CAR T-CELL THERAPY TARGETING CD84 ALONE OR IN COMBINATION WITH CD19 FOR THE TREATMENT OF B-CELL MALIGNANCIES

EHA Library, Ane Altuna, 419506

CAR T CELLS RESIDE IN THE BONE MARROW AND INHIBIT HEMATOPOIESIS

EHA Library, Camille Bigenwald, 419507

LONGITUDINAL SINGLE CELL MULTIOMIC ANALYSIS ALLOW THE IDENTIFICATION OF MECHANISM OF PERSISTENCE AND RESISTANCE TO CAR-T CELLS IN MM

EHA Library, Ana ALFONSO PIEROLA, 419508

WU-NK-101 IS AN OFF-THE-SHELF MEMORY NK CELL WITH A TME-RESILIENT, ANTI-TUMOR PHENOTYPE THAT CAN BE DETECTED IN R/R AML PATIENT PBMC AFTER INFUSION

EHA Library, Sergio Rutella, 419509

THE DIVERSITY AND COMPOSITION OF THE T CELL REARRANGEMENT REPERTOIRE IS ASSOCIATED WITH PROGNOSIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH CAR-T CELL THERAPIES

EHA Library, Alejandro Medina-Herrera, 419510

A NOVEL NANOPARTICLE-BASED IMMUNOTHERAPY FOR ITTP. AUTOANTIGEN-LOADED LIPOSOMES TO RESTORE SELF-TOLERANCE

EHA Library, Daniela Greco, 419511

REAL-WORLD MANUFACTURING EXPERIENCE OF AXICABTAGENE CILOLEUCEL FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA TREATED IN SECOND LINE VERSUS THIRD LINE OF THERAPY AND BEYOND

EHA Library, Jason Westin, 419512

CORRELATIONS BETWEEN (CAR) T-CELL METABOLIC AND PHENOTYPICAL STATE AND CLINICAL OUTCOME OF CAR T-CELL THERAPY FOR LARGE B-CELL LYMPHOMA

EHA Library, Arnon P. Kater, 419513

ACQUISITION OF AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AFTER CD19 CAR T CELL TREATMENT IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marianna Ponzo, 419514

STAT5 IS ESSENTIAL FOR INDUCING THE SUPPRESSIVE SUBSET AND ATTENUATE CYTOTOXICITY OF VΔ2+ T CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, cong cheng, 419515

SENESCENCE AND INFLAMMATION ARE ADVERSE UNCHARTED BARRIERS TO EFFICIENT CRISPR-CAS9 GENE-EDITING IN HEMATOPOIETIC STEM CELLS

EHA Library, Anastasia Conti, 419516

DIFFERENTIAL EXPRESSION OF COMPLEMENT-INTERFERON LOOP BEFORE CART THERAPY IN PATIENTS THAT DEVELOP CYTOKINE RELEASE SYNDROME

EHA Library, Maria georgia Koutra, 419517

TRANSCRIPTOMIC SIGNATURES IN T-CELLS COULD HELP TO PREDICT RESPONSE TO CAR T-CELLS IN PATIENTS WITH AGGRESSIVE B CELL LYMPHOMA

EHA Library, Ismael De La Iglesia San Sebastián, 419518

SUSTAINED CORRECTION OF HEREDITARY ANTITHROMBIN DEFICIENCY IN MICE BY AAV8-MEDIATEDGENE DELIVERY

EHA Library, Yanyi Tao, 419519

ADI-270: AN ARMORED ALLOGENEIC ANTI-CD70 CAR GAMMA-DELTA T CELL THERAPY DESIGNED FOR MULTIPLE SOLID AND HEMATOLOGICAL CANCER INDICATIONS

EHA Library, Yvan Chanthery, 419520

SPECIFIC AND PERSONALISED TARGETING OF ANTI-ADAMTS13 AUTOREACTIVE B CELLS IN IMMUNE-MEDIATED TTP USING SWITCHABLE REVCAR T CELLS.

EHA Library, Rutuja Gupte, 419521

PREVALENCE, ETIOLOGY, AND OUTCOME OF DELAYS BETWEEN INITIATION OF LYMPHODEPLETING CHEMOTHERAPY AND CAR T CELL INFUSION

EHA Library, Yannis Valtis, 419522

CIRCULATING T LYMPHOCYTE SUBSETS ON DAY +7 AFTER VARNIMCABTAGENE AUTOLEUCEL (ARI-0001) IN B-CELL NON-HODGKIN LYMPHOMA ARE ABLE TO PREDICT EFFICACY AND TOXICITY

EHA Library, Andrea Rivero Arango, 419523

LONG TERM SURVIVAL IN AML PATIENTS AFTER IMMUNOTHERAPY WITH VIDIDENCEL CORRELATES WITH FUNCTIONAL T AND B-CELL RESPONSES

EHA Library, Arjan van de Loosdrecht, 419524

INATICABTAGENE AUTOLEUCEL(CNCT19) IN RELAPSED OR REFRACTORY B-CELL LYMPHOMA: RESULTS OF A PHASE I CLINICAL TRIAL

EHA Library, Wei Liu, 419525

DENDRITIC CELL-BASED VACCINES (KSD-101) AGAINST EBV-ASSOCIATED HEMATOLOGIC NEOPLASMS: RESULTS FROM AN ONGOING PHASE I CLINICAL STUDY

EHA Library, Chunrui Li, 419526

IMPLICATIONS OF CAR T CELL REFERRAL AND APHERESIS DELAYS ON OUTCOMES AND TOXICITY IN LYMPHOMA PATIENTS

EHA Library, Alexander Boardman, 419527

IMMUNE RECONSTITUTION FOLLOWING CD19 CAR-T FOR R/R B-NHL IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES AND IS IMPAIRED AT TIME OF POST-CAR-T PROGRESSION

EHA Library, Sophia Stock, 419528

IMMUNOGENETIC PROFILING OF EX VIVO GENERATED PATHOGEN-SPECIFIC T CELLS FOR IMMUNOTHERAPY OF OPPORTUNISTIC INFECTIONS POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Chrysa Pantazi, 419529

SECONDARY MYELOID MALIGNANCIES FOLLOWING CAR T-CELL THERAPY FOR B-CELL MALIGNANCIES: A RETROSPECTIVE ANALYSIS

EHA Library, Amaris Balitsky, 419530

FREQUENCY OF CAR-T CELL MANUFACTURING FAILURES AND OUT-OF-SPECIFICATION PRODUCTS IN THE REAL-WORLD SETTING: A SURVEY FROM THE EBMT CELLULAR THERAPY AND IMMUNOBIOLOGY WORKING PARTY (CTIWP)

EHA Library, Nina Worel, 419532

CAR-HEMATOTOX SCORE PREDICTS OVERALL SURVIVAL IN LARGE B-CELL LYMPHOMAS TREATED WITH ANTI-CD19 CAR T-CELLS: A SUBGROUP ANALYSIS OF CART-SIE

EHA Library, Federico Stella, 419533

POINT-OF-CARE NON-VIRAL PRODUCTION OF CD19 CHIMERIC ANTIGEN RECEPTOR-T CELLS WITH ENHANCED TSCM IMMUNOPHENOTYPE FOR THERAPY OF REFRACTORY B-CELL MALIGNANCIES- PRELIMINARY RESULTS OF PHASE I CLINICAL TRIAL

EHA Library, Pavel Otáhal, 419534

LONG TERM FOLLOW-UP RESULTS OF BRL-201 PHASE I STUDY, A CRISPR-BASED NON-VIRAL PD-1 LOCUS SPECIFIC INTEGRATED ANTI-CD19 CAR-T CELLS IN TREATING RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA

EHA Library, Biao Zheng, 419535

CAR T TREATMENT ACCESS AND OUTCOMES IN PATIENTS WITH LARGE B-CELL LYMPHOMA ACCORDING TO ETHNICITY AND SOCIOECONOMIC DEPRIVATION IN THE UK

EHA Library, Oana Diana Dragoi, 419536

CHANGING THE NATURAL HISTORY OF PYRUVATE KINASE DEFICIENCY WITH LENTIVIRAL-MEDIATED GENE THERAPY: RESULTS OF A GLOBAL PHASE 1 STUDY

EHA Library, Julian Sevilla, 419537

EARLY AND LATE INTRODUCTION OF CAR T-CELL THERAPY IN LARGE B-CELL LYMPHOMA HAVE COMPARABLE TOXICITY AND EFFICACY OUTCOMES

EHA Library, Magdalena Corona de Lapuerta, 419538

TWO-YEAR FOLLOW-UP RESULTS OF C-CAR066, A NOVEL ANTI-CD20 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS AFTER FAILURE OF CD19 CAR-T THERAPY

EHA Library, Dehui Zou, 419539

FIRST RESULTS OF A COMPREHENSIVE PROSPECTIVE PROTOCOL OF RADIOTHERAPY BRIDGING AND CONSOLIDATION FOR CAR T IN LARGE B-CELL LYMPHOMA (RESTART)

EHA Library, Christianne Bourlon, 419541

CLINICAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH TISAGENLECLEUCEL: PHASE 2 ELARA 3-YEAR FOLLOW-UP

EHA Library, Martin Dreyling, 419542

ASSOCIATION BETWEEN BODY MASS INDEX AND OUTCOMES OF CAR-T THERAPY ACROSS HEMATOLOGIC MALIGNANCIES

EHA Library, Yannis Valtis, 419543

AFTER PROPENSITY SCORE WEIGHTING AXICABTAGENE CILOLEUCEL CONFER SUPERIOR PROGRESSION-FREE SURVIVAL COMPARED TO TISAGENLECLEUCEL IN LARGE B-CELL LYMPHOMAS: FINAL RESULTS OF THE ITALIAN CART-SIE STUDY

EHA Library, Federico Stella, 419544

LONG-TERM DURABLE RESPONSES IN PATIENTS WITH R/R ALL, DLBCL, AND FL TREATED WITH TISAGENLECLEUCEL AND ITS ASSOCIATION WITH PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

EHA Library, Harald Maier, 419545

FIRST REAL-WORLD EXPERIENCE OF COMMERCIAL RELMACABTAGENE AUTOLEUCEL (RELMA-CEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA: A MULTICENTER RETROSPECTIVE ANALYSIS OF PATIENTS IN CHINA

EHA Library, Wenyan Yu, 419546

INB-100: PILOT STUDY OF DONOR DERIVED, EX-VIVO EXPANDED/ACTIVATED GAMMA-DELTA T CELL INFUSION FOLLOWING HAPLOIDENTICAL HEMATOPOIETIC STEM-CELL TRANSPLANTATION  AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

EHA Library, Joseph McGuirk, 419547

HIGH EFFICACY AND FAVORABLE SAFETY OF CD20-TARGETED CAR-T THERAPY FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL)

EHA Library, Brian Till, 419548

HEMATOPOIETIC STEM CELL GENE THERAPY FOR HURLER SYNDROME: INTERIM SKELETAL, NEUROLOGICAL AND SYSTEMIC OUTCOMES

EHA Library, Maria Ester Bernardo, 419549

CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IS FEASIBLE IN PATIENTS 80 YEARS OF AGE OR OLDER WITH B-CELL LYMPHOMA: A US MULTICENTER COLLABORATIVE STUDY

EHA Library, Julio Chavez, 419550

ALLOGENIC STEM CELL TRANSPLANT (SCT) AFTER CAR-T CELL THERAPY FOR RELAPSE OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) IN PEDIATRIC PATIENTS. A SINGLE CENTER EXPERIENCE

EHA Library, Anna Alonso-Saladrigues, 419553